Latest

19:36
【FOSUN PHARMA (02196.HK): Taohong Siwu Decoction Granules Registration Application Accepted by NMPA】NewTimeSpace News: Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196.HK) announced that the drug registration application for Taohong Siwu Decoction Granules submitted by its controlling subsidiary Hebei Wanbang Fulin Pharmaceutical Co., Ltd. has been accepted by the National Medical Products Administration (NMPA). As a Class 3.1 new traditional Chinese medicine, the formulation originates from Fuke Bingjian by Qing-dynasty physician Chai Dehua and is included in the First Catalogue of Ancient Classic Prescriptions issued by the State Administration of Traditional Chinese Medicine.
Tag： FOSUN PHARMA02196.HKdrug registration application
19:16
【BABA-W(09988.HK): FY 25/26 Annual Report - Profit Attributable to Shareholders stood at CNY 103.59 billion, YoY decrease of 20.38%】NewTimeSpace News: May 13, 2026, BABA-W(09988.HK) released its Annual Report for the period ended March 31, 2026, Total Revenue stood at CNY 1023.67 billion, increased by 2.74% YoY
Tag： BABA-W09988.HKfinancials
18:07
【CSTONE PHARMA-B(02616.HK): Proposes Open-Market Share Repurchase of Up to 136.45 Million Shares】NewTimeSpace News: CStone Pharmaceuticals (02616.HK) announced its proposal to repurchase up to 136,450,133 shares from time to time on the open market. The share repurchase plan is expected to be implemented after the ASCO Annual Meeting, fully demonstrating the management and the Board’s firm confidence in the Company’s R&D achievements, commercial progress and long-term business development.
Tag： CSTONE PHARMA-B02616.HKShare Repurchase
17:59
【China Carbon Neutral (01372.HK): Proposed Issuance of Approximately 96.59 Million New Shares, Raising Net Proceeds of About HK$77.27 Million】NewTimeSpace News: On May 13, China Carbon Neutral announced that the company has entered into a subscription agreement with three subscribers, proposing to issue a total of approximately 96.59 million new shares at HK$0.80 per share, with net proceeds of around HK$77.27 million.
Tag： China Carbon Neutral01372.HK
17:53
【POU SHENG INT'L(03813.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 183.32 million, YoY increase of 32.49%】NewTimeSpace News: May 13, 2026, POU SHENG INT'L(03813.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at CNY 5.05 billion, decreased by 1.09% YoY
Tag： POU SHENG INTL03813.HKfinancials
17:52
【YUE YUEN IND(00551.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at USD 35.18 million, YoY decrease of 53.56%】NewTimeSpace News: May 13, 2026, YUE YUEN IND(00551.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at USD 1.99 billion, decreased by 2.17% YoY
Tag： YUE YUEN IND00551.HKfinancials
17:51
【TCL ELECTRONICS(01070.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at HKD 359.34 million, YoY increase of 123.63%】NewTimeSpace News: May 13, 2026, TCL ELECTRONICS(01070.HK) released its Q1 Report for the period ended December 31, 2026, Total Revenue stood at HKD 29.23 billion, increased by 15.28% YoY
Tag： TCL ELECTRONICS01070.HKprofit
17:38
【GF Securities (01776.HK): Perpetual Subordinated Bond "23 GF Y3" to Pay Interest on May 15】NewTimeSpace News: On May 13, GF Securities announced that the Company’s publicly issued 2023 Perpetual Subordinated Bond (Tranche 3) will pay interest on May 15, 2026.
Tag： GF Securities01776.HK
17:14
【HANS CNC(03200.HK) closed 30.91% higher, closing at HKD 185】NewTimeSpace News: By the close of trading on May 13, 2026, HANS CNC(03200.HK) saw a gain of 30.91% in its share price, closing at HKD 185. During the session, it reached an intraday high of HKD 189 and touched an intraday low of HKD 138.5.
Tag： HANS CNC03200.HKclosing price
17:12
【Henlius (02696.HK): HLX48 (EGFR/c-MET Dual-target ADC) Secures Australian Approval for Phase I Clinical Trial】NewTimeSpace News: Shanghai Henlius Biotech, Inc. (02696.HK) announced that the Phase I clinical trial of its self-developed HLX48 for injection, an EGFR/c-MET dual-target antibody-drug conjugate (ADC) for advanced/metastatic solid tumors, has been approved by the relevant Human Research Ethics Committee and completed clinical trial notification with Australia’s Therapeutic Goods Administration (TGA). No 同类 bispecific ADC has been approved globally so far.
Tag： HENLIUS02696.HKPhase I clinical trial
17:07
【Henlius (02696.HK): HLX97 (KAT6A/B Inhibitor) Completes First Patient Dosing in Phase I Clinical Trial for Advanced Solid Tumors】NewTimeSpace News: Shanghai Henlius Biotech, Inc. (02696.HK) announced that its self-developed HLX97, a KAT6A/B small-molecule inhibitor, has completed first patient dosing in China for the Phase I clinical trial in patients with advanced/metastatic solid tumors. The candidate is intended for the treatment of advanced and metastatic solid tumors, and no KAT6A/B small-molecule inhibitor has been approved worldwide to date.
Tag： HENLIUS02696.HKPhase I clinical trial
17:05
【INNOSCIENCE(02577.HK) closed 19.26% higher, the Hang Seng Semiconductors Sector saw divergent trends】By the close of trading on May 13, 2026, INNOSCIENCE(02577.HK) saw a gain of 19.26% in its share price, closing at HKD 83.6. During the session, it reached an intraday high of HKD 84.85 and touched an intraday low of HKD 68.6.
Tag： INNOSCIENCE02577.HKclosing price
16:28
【iShares Hang Seng TECH ETF (03067.HK) rose 0.56% to close at HKD 10.720】Newtimespace News, as of May 13, iShares Hang Seng TECH ETF (03067.HK) rose 0.56% to close at HKD 10.720. During the session, its highest price was HKD 10.770, and the lowest price touched HKD 10.540.
Tag： ETFiShares Hang Seng TECH ETF03067.HK
16:27
【SINGAPORE INST OF ADV MED: Secures SGX-ST Approval to Issue Up to Approximately 493 Million Rights Shares and Free Warrants】NewTimeSpace News: On May 12, SINGAPORE INST OF ADV MED announced that it has received the listing and quotation notice from SGX-ST, approving the issuance of up to approximately 493 million rights shares and an equivalent number of free warrants on the basis of two rights shares for every five existing shares held.
Tag： SINGAPORE INST OF ADV MEDFree WarrantsSGX
16:25
【Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) fell 1.16% to close at HKD 14.530】Newtimespace News, as of May 13, Chinaamc Hang Seng Hong Kong Biotech Index ETF(03069.HK) fell 1.16% to close at HKD 14.530. During the session, its highest price was HKD 14.760, and the lowest price touched HKD 14.490.
Tag： ETFChinaamc Hang Seng Hong Kong Biotech Index ETF03069.HK
16:22
【Hang Seng China Enterprises Index ETF(02828.HK) edged down 0.24% to close at HKD 90.960】Newtimespace News, as of May 13, Hang Seng China Enterprises Index ETF(02828.HK) edged down 0.24% to close at HKD 90.960. During the session, its highest price was HKD 91.380, and the lowest price touched HKD 90.380.
Tag： ETFHang Seng China Enterprises Index ETF02828.HK
16:16
【NATSTORAGE: A$300 Million Exchangeable Notes to Be Redeemed Early on June 9】NewTimeSpace News: On May 13, NATSTORAGE announced that the delisting of the underlying securities from the Australian Securities Exchange due to a takeover transaction has triggered the issuer’s redemption right. The issuer has notified that it will redeem all outstanding 3.625% exchangeable notes at par on 9 June 2026, with a total redemption amount of approximately A$10.786 million.
Tag： NATSTORAGEExchangeable NotesRedeemed
16:14
【CHINAHONGQIAO(01378.HK) will spend HKD 275.63 million to repurchase 8.27 million shares on May 12, 2026】NewTimeSpace News: CHINAHONGQIAO(01378.HK) will spend HKD 275.63 million to repurchase 8.27 million shares on May 12, 2026.
Tag： CHINAHONGQIAO01378.HKrepurchase
16:01
【Bosera SZSE ChiNext Daily (2x) Leveraged Product (07234.HK) Rises 5.60% to HKD 13.200】Newtimespace News: As of 15:57 on May 13, Bosera SZSE ChiNext Daily (2x) Leveraged Product (07234.HK) rose 5.60% to HKD 13.200, with a turnover of approximately HKD 15.3392 million and assets under management of approximately HKD 216 million.
Tag： Bosera Szse Chinext Daily (2x) Leveraged Product07234.HKETF
15:57
【iShares FTSE China A50 ETF (02823.HK) Rises 0.62%,assets under management of approximately HKD 16.228 billion】Newtimespace News: As of 15:51 on May 13, iShares FTSE China A50 ETF (02823.HK) rose 0.62% to HKD 17.860, with a turnover of approximately HKD 26.2647 million and assets under management of approximately HKD 16.228 billion.
Tag： Ishares Ftse China A50 Etf02823.HKETF
Previous1..362363 364365366..488     488 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments